Cellebrite DI Ltd. logo

Cellebrite DI Ltd. (CLBT)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
15. 44
-0.39
-2.4637%
$
4.02B Market Cap
- P/E Ratio
- Div Yield
1.09M Volume
- Eps
$ 15.83
Previous Close
Add Transaction
Day Range
15.24 15.9
Year Range
11.02 19.98
Want to track CLBT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cellebrite DI Ltd. (CLBT) Soars to 52-Week High, Time to Cash Out?

Cellebrite DI Ltd. (CLBT) Soars to 52-Week High, Time to Cash Out?

Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future?

Zacks | 1 year ago
Cellebrite DI Ltd. (CLBT) Q2 2024 Earnings Call Transcript

Cellebrite DI Ltd. (CLBT) Q2 2024 Earnings Call Transcript

Cellebrite DI Ltd. (NASDAQ:CLBT ) Q2 2024 Earnings Conference Call August 15, 2024 8:30 AM ET Company Participants Andrew Kramer - IR Yossi Carmil - CEO Dana Gerner - CFO Conference Call Participants Brad Zelnick - Deutsche Bank Mike Cikos - Needham Eric Martinuzzi - Lake Street Shaul Eyal - TD Cowen Jeff Van Rhee - Craig-Hallum Brian Essex - JPMorgan Louie DiPalma - William Blair Tomer Zilberman - Bank of America Operator Welcome to the Cellebrite Second Quarter 2024 Financial Results Conference Call.

Seekingalpha | 1 year ago
Cellebrite DI Ltd. (CLBT) Tops Q2 Earnings and Revenue Estimates

Cellebrite DI Ltd. (CLBT) Tops Q2 Earnings and Revenue Estimates

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.08 per share.

Zacks | 1 year ago
Cellebrite DI Ltd. (CLBT) Hits Fresh High: Is There Still Room to Run?

Cellebrite DI Ltd. (CLBT) Hits Fresh High: Is There Still Room to Run?

Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future?

Zacks | 1 year ago
Cellebrite DI Ltd. (CLBT) Soars 6.1%: Is Further Upside Left in the Stock?

Cellebrite DI Ltd. (CLBT) Soars 6.1%: Is Further Upside Left in the Stock?

Cellebrite DI Ltd. (CLBT) witnessed a jump in share price last session on above-average trading volume.

Zacks | 2 years ago
Cellebrite: Very Strong Competitive Advantage That Is Hard To Replicate

Cellebrite: Very Strong Competitive Advantage That Is Hard To Replicate

Cellebrite has a strong competitive advantage as the gold standard in digital forensics, making it difficult for new players to replicate or displace. CLBT serves a mission-critical function in digital investigations for law enforcement, with a majority of revenue coming from subscriptions. Up/cross selling opportunities and penetration into adjacent functions are key drivers for CLBT's future earnings growth.

Seekingalpha | 2 years ago
Cellebrite DI Ltd. (CLBT) Q1 2024 Earnings Call Transcript

Cellebrite DI Ltd. (CLBT) Q1 2024 Earnings Call Transcript

Cellebrite DI Ltd. (NASDAQ:CLBT ) Q1 2024 Earnings Call Transcript May 23, 2024 8:30 AM ET Company Participants Andrew Kramer - IR Yossi Carmil - CEO Dana Gerner - CFO Conference Call Participants Shaul Eyal - TD Cowen Jonathan Ho - William Blair Mike Cikos - Needham Eric Martinuzzi - Lake Street Brian Essex - JPMorgan Jeff Van Rhee - Craig-Hallum Louie DiPalma - William Blair Tomer Zilberman - Bank of America Operator Welcome to the Cellebrite First Quarter 2024 Financial Results Conference Call.

Seekingalpha | 2 years ago
Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Surpass Estimates

Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Surpass Estimates

Cellebrite DI Ltd. (CLBT) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share.

Zacks | 2 years ago